T. Rowe Price Associates’s Enact Holdings ACT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56M Buy
34,211
+5,592
+20% +$239K ﹤0.01% 2124
2026
Q1
$1.17M Buy
28,619
+7,077
+33% +$289K ﹤0.01% 2077
2025
Q4
$854K Sell
21,542
-3,909
-15% -$147K ﹤0.01% 2150
2025
Q3
$976K Buy
25,451
+1,338
+6% +$49.6K ﹤0.01% 2084
2025
Q2
$896K Buy
24,113
+3,077
+15% +$109K ﹤0.01% 2033
2025
Q1
$732K Buy
21,036
+9,660
+85% +$323K ﹤0.01% 2100
2024
Q4
$369K Buy
11,376
+1,797
+19% +$62.2K ﹤0.01% 2418
2024
Q3
$349K Buy
9,579
+346
+4% +$11.8K ﹤0.01% 2408
2024
Q2
$284K Buy
9,233
+772
+9% +$23.5K ﹤0.01% 2442
2024
Q1
$264K Buy
8,461
+1,161
+16% +$32.9K ﹤0.01% 2490
2023
Q4
$211K Buy
+7,300
New +$204K ﹤0.01% 2519

Other funds holding ACT

T. Rowe Price Associates's ACT Position: Q2 2026 in Review

T. Rowe Price Associates increased its Enact Holdings (ACT) stake by 20% in Q2 2026, buying an estimated $239K and bringing the position to 34,211 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2124.

T. Rowe Price Associates first reported a position in ACT in Q4 2023 and has held it in 11 quarters since. 251 funds tracked by Wall St. Rank hold ACT as of Q2 2026.

  • T. Rowe Price Associates held 34,211 shares of Enact Holdings worth $1.56M as of Q2 2026.
  • T. Rowe Price Associates bought 5,592 Enact Holdings shares in Q2 2026, an estimated $239K.
  • Enact Holdings made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2124 holding.
  • T. Rowe Price Associates first reported a position in Enact Holdings in Q4 2023 and has held it in 11 quarters since.
  • 251 funds tracked by Wall St. Rank held Enact Holdings as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.